Nutex Health Inc (NUTX)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Nutex Health Inc (NUTX) P/E Ratio & Valuation History
Nutex Health (NUTX) trades at 7.5x trailing earnings and 1.5x sales. Its P/B of 2.7x is above its 5-year median of 2.6x. The median P/E across 7 similar companies is 28.8x.
Current Multiples
Its enterprise value is 3.7x its EBITDA. Its free cash flow yield is 21.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 7.5x |
| Forward P/E | N/A |
| Price to sales | 1.5x |
| Price to book | 2.7x |
| EV/EBITDA | 3.7x |
| Price to FCF | 4.7x |
| EV/FCF | 5.0x |
| PEG | N/A |
| FCF yield | 21.3% |
Historical Medians
Against its 10-year medians, its P/B is 12.5% above 2.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 2.7x | 2.6x | 2.4x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/B, its P/B ranged from 0.5x in 2018 to 364.1x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $164.62 | 10.0x | 1.3x | 3.6x |
| 2024 | $31.69 | 3.0x | N/A | 1.1x |
| 2023 | $26.99 | N/A | 0.5x | 1.9x |
| 2022 | $284.86 | N/A | N/A | 14.6x |
| 2021 | $617.69 | N/A | N/A | N/A |
| 2020 | $202.40 | N/A | N/A | 2.2x |
| 2019 | $299.85 | N/A | N/A | 364.1x |
| 2018 | $374.81 | N/A | N/A | 0.5x |
| 2017 | $3,748.13 | N/A | N/A | 1.0x |
| 2016 | $5,247.38 | N/A | N/A | N/A |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NUTX
Is NUTX stock overvalued?
GNG's valuation label for NUTX is Fairly valued. Its P/E of 7.5x compares with a median of 28.8x across 7 similar companies.
What is NUTX's price to sales ratio?
Nutex Health has a price to sales ratio of 1.5x.
NUTX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors